Yitao Wang

11.0k total citations · 2 hit papers
224 papers, 8.7k citations indexed

About

Yitao Wang is a scholar working on Molecular Biology, Pharmacology and Complementary and alternative medicine. According to data from OpenAlex, Yitao Wang has authored 224 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Molecular Biology, 41 papers in Pharmacology and 39 papers in Complementary and alternative medicine. Recurrent topics in Yitao Wang's work include Ginseng Biological Effects and Applications (38 papers), Traditional Chinese Medicine Analysis (26 papers) and Natural product bioactivities and synthesis (25 papers). Yitao Wang is often cited by papers focused on Ginseng Biological Effects and Applications (38 papers), Traditional Chinese Medicine Analysis (26 papers) and Natural product bioactivities and synthesis (25 papers). Yitao Wang collaborates with scholars based in Macao, China and United States. Yitao Wang's co-authors include Jin‐Jian Lu, Xiuping Chen, Meiwan Chen, Jian‐Bo Wan, Jiaolin Bao, Shengpeng Wang, Xu Wu, Shengpeng Wang, Ying Zheng and Wen Siang Tan and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Advanced Drug Delivery Reviews.

In The Last Decade

Yitao Wang

218 papers receiving 8.5k citations

Hit Papers

Polymeric micelles drug delivery system in oncology 2012 2026 2016 2021 2012 2019 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yitao Wang Macao 47 4.2k 1.4k 1.3k 1.2k 1.0k 224 8.7k
Boyang Yu China 46 5.2k 1.2× 1.2k 0.8× 922 0.7× 1.5k 1.2× 1.3k 1.3× 489 9.5k
Sahdeo Prasad United States 53 5.4k 1.3× 1.4k 1.0× 1.3k 1.0× 1.0k 0.8× 1.3k 1.3× 108 12.3k
Jian‐Bo Wan Macao 51 4.5k 1.1× 1.3k 0.9× 675 0.5× 1.1k 0.9× 1.0k 1.0× 256 8.8k
Wei Wang China 52 5.1k 1.2× 980 0.7× 1.1k 0.8× 693 0.6× 1.1k 1.0× 459 10.8k
Lixia Chen China 49 4.8k 1.1× 1.0k 0.7× 1.0k 0.8× 1.8k 1.5× 1.2k 1.1× 506 11.7k
Wei Xiao China 44 3.6k 0.9× 1.4k 1.0× 944 0.7× 1.5k 1.2× 958 0.9× 433 7.9k
Jin‐Jian Lu Macao 55 5.6k 1.3× 1.2k 0.8× 1.3k 1.0× 1.0k 0.9× 1.1k 1.1× 237 9.8k
Chong‐Zhi Wang United States 52 5.9k 1.4× 2.5k 1.7× 1.2k 0.9× 1.3k 1.1× 1.2k 1.1× 222 9.5k
Min Ye China 58 7.1k 1.7× 2.9k 2.0× 1.5k 1.2× 1.9k 1.5× 1.9k 1.8× 413 12.1k
Yitao Wang Macao 62 6.7k 1.6× 1.8k 1.3× 1.7k 1.3× 1.9k 1.6× 2.1k 2.0× 359 14.2k

Countries citing papers authored by Yitao Wang

Since Specialization
Citations

This map shows the geographic impact of Yitao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yitao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yitao Wang more than expected).

Fields of papers citing papers by Yitao Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yitao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yitao Wang. The network helps show where Yitao Wang may publish in the future.

Co-authorship network of co-authors of Yitao Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yitao Wang. A scholar is included among the top collaborators of Yitao Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yitao Wang. Yitao Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vong, Chi Teng, et al.. (2024). Ginsenoside Rk1 Ameliorates ER Stress-Induced Apoptosis through Directly Activating IGF-1R in Mouse Pancreatic β-Cells and Diabetic Pancreas. The American Journal of Chinese Medicine. 52(4). 1195–1211. 6 indexed citations
2.
Miao, Lingchao, Yan Zhou, Dechao Tan, et al.. (2024). Ginsenoside Rk1 improves endothelial function in diabetes through activating peroxisome proliferator-activated receptors. Food & Function. 15(10). 5485–5495. 15 indexed citations
3.
Wu, Mingyue, Ying Zheng, Richard D. Ye, et al.. (2023). Targeting macrophage autophagy for inflammation resolution and tissue repair in inflammatory bowel disease. Burns & Trauma. 11. tkad004–tkad004. 24 indexed citations
4.
Tan, Dechao, et al.. (2022). Glycyrrhizic Acid and Its Derivatives: Promising Candidates for the Management of Type 2 Diabetes Mellitus and Its Complications. International Journal of Molecular Sciences. 23(19). 10988–10988. 35 indexed citations
5.
Zhao, Yi, Shengpeng Wang, Hu Y, & Yitao Wang. (2022). Investigating Key Targets of Dajianzhong Decoction for Treating Crohn’s Disease Using Weighted Gene Co-Expression Network. Processes. 11(1). 112–112.
6.
Zhong, Zhangfeng, Chi Teng Vong, Feiyu Chen, et al.. (2022). Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: Helping to fight against cancer via multiple targets. Medicinal Research Reviews. 42(3). 1246–1279. 79 indexed citations
7.
Wu, Mingyue, Le Liu, Haitao Xiao, et al.. (2020). PI3KC3 complex subunit NRBF2 is required for apoptotic cell clearance to restrict intestinal inflammation. Autophagy. 17(5). 1096–1111. 65 indexed citations
8.
Liu, Peng, Caifang Gao, Hongguo Chen, et al.. (2020). Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: Opportunities and emerging strategies. Acta Pharmaceutica Sinica B. 11(9). 2798–2818. 120 indexed citations
9.
Qu, Liping, Qing Shi, Huimin Zeng, Yitao Wang, & Wenjun Zou. (2017). Analysis on value of Community Herbal Monograph in registration of traditional Chinese medicinal products in Europe. Zhongcaoyao. 1916–1920.
10.
Tan, Wen, Virginia L. Scofield, Ke Tian, et al.. (2016). Furanodiene alters mitochondrial function in doxorubicin-resistant MCF-7 human breast cancer cells in an AMPK-dependent manner. Molecular BioSystems. 12(5). 1626–1637. 27 indexed citations
11.
Ung, Carolina Oi Lam, et al.. (2015). Community pharmacists’ perceptions about pharmaceutical care of OTC western medicine: a survey in Harbin of China. International Journal of Clinical Pharmacy. 37(6). 1014–1020. 10 indexed citations
12.
Zhang, Maoyu, Jin‐Jian Lu, Liang Wang, et al.. (2015). Development of Monoclonal Antibodies in China: Overview and Prospects. BioMed Research International. 2015. 1–10. 9 indexed citations
13.
Yan, Zhixiang, Ge Lin, Yang Ye, Yitao Wang, & Ru Yan. (2014). Triterpenoid saponins profiling by adducts-targeted neutral loss triggered enhanced resolution and product ion scanning using triple quadrupole linear ion trap mass spectrometry. Analytica Chimica Acta. 819. 56–64. 36 indexed citations
15.
Hu, Hao, et al.. (2012). Provision and Usage of Medical Services by Community Pharmacy: A Comparative Study of New York, Macao and Zhuhai (China). Canadian social science. 8(6). 11–17. 2 indexed citations
16.
Wang, Yitao. (2012). Research Progress in the Anti-tumor Effects and Mechanisms of Matrine and Oxymatrine. Traditional Chinese Drug Research and Clinical Pharmacology. 1 indexed citations
18.
Wang, Yitao. (2011). Equity analysis of hospital beds distribution in Mainland China. 1 indexed citations
19.
Chen, Xiuping, Lixia Pei, Zhangfeng Zhong, et al.. (2011). Anti-tumor potential of ethanol extract of Curcuma phaeocaulis Valeton against breast cancer cells. Phytomedicine. 18(14). 1238–1243. 68 indexed citations
20.
Wang, Yitao. (2008). Effects of Nitrogen Fertilizer Rate on Oat Photosynthetic Character and Canopy Structure. Acta Agriculturae Boreali-Sinica. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026